Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Educational Seminars: Learn how to make informed decisions about your health
Israels Teva Pharmaceutical Industries the worlds largest generic drugmaker, launched a generic version of Victoza in the US on Monday
PepT1-mediated uptake: Km ~160 uM in intestinal epithelial cells and ~700 uM in Jurkat immune cells (Dalmasso 2008)
A new retail metabolic wellness lane and higher consumer expectations Labels move from high protein and good source of fibre to supports satiety, with on-pack summaries and QR links to readable study briefs
All descriptions are based on published research and publicly available information from the brand's official website
In agreement with expectations, the first outcome trial of a GLP-1RA, the ELIXA trial of the short-acting lixisenatide, an exendin-4 derivative with properties almost identical to those of exendin-4 or exenatide (stable, full agonists of the GLP-1 receptor), showed no increased cardiovascular risk in a patient group with severely increased CVD risk
US$ 26.89
US$ 21.80
US$ 24.53
US$ 28.48
